Publication | Closed Access

Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study

Surgical OncologySurvival OutcomesNeoadjuvant CemiplimabMedicineSurgeryDermatological SurgeryDermatologyPhase 2Cancer TreatmentOncologyMolecular OncologySkin Cancer